These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3162680)

  • 21. Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
    Kissebah AH; Alfarsi S; Evans DJ
    Arteriosclerosis; 1984; 4(6):614-24. PubMed ID: 6508636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Stuyt PM; Mol MJ; Stalenhoef AF; Demacker PN; Van 't Laar A
    Am J Med; 1990 Jan; 88(1N):42N-45N. PubMed ID: 2368763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination drug therapy for familial combined hyperlipidemia.
    East C; Bilheimer DW; Grundy SM
    Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins.
    Arad Y; Ramakrishnan R; Ginsberg HN
    Metabolism; 1992 May; 41(5):487-93. PubMed ID: 1588827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.
    Vázquez M; Zambón D; Hernández Y; Adzet T; Merlos M; Ros E; Laguna JC
    Br J Clin Pharmacol; 1998 Mar; 45(3):265-9. PubMed ID: 9517370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
    Tremblay AJ; Lamarche B; Ruel IL; Hogue JC; Deshaies Y; Gagné C; Couture P
    Atherosclerosis; 2006 Sep; 188(1):203-12. PubMed ID: 16337207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
    Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-VLDL accumulation in familial dysbetalipoproteinemia is associated with increased exchange or diffusion of chylomicron lipids to apo B-100 containing triglyceride-rich lipoproteins.
    Demacker PN; Bredie SJ; Vogelaar JM; Hectors MP; van Heijst P; Stuyt PM; Stalenhoef AF
    Atherosclerosis; 1998 Jun; 138(2):301-12. PubMed ID: 9690913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of obesity on the metabolism of apolipoprotein B in humans.
    Egusa G; Beltz WF; Grundy SM; Howard BV
    J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human triglyceride-rich lipoprotein apo E kinetics and its relationship to LDL apo B-100 metabolism.
    Millar JS; Lichtenstein AH; Ordovas JM; Dolnikowski GG; Schaefer EJ
    Atherosclerosis; 2001 Apr; 155(2):477-85. PubMed ID: 11254920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA; Grundy SM
    JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary fat saturation in rhesus monkeys affects LDL concentrations by modulating the independent production of LDL apolipoprotein B.
    Khosla P; Hayes KC
    Biochim Biophys Acta; 1991 Apr; 1083(1):46-56. PubMed ID: 2031937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs.
    Huff MW; Telford DE; Barrett PH
    Arterioscler Thromb; 1992 Aug; 12(8):902-10. PubMed ID: 1637788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of cholesterol synthesis reduces low-density-lipoprotein apoprotein B production without decreasing very-low-density-lipoprotein apoprotein B synthesis in rabbits.
    La Ville A; Moshy R; Turner PR; Miller NE; Lewis B
    Biochem J; 1984 Apr; 219(1):321-3. PubMed ID: 6562889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
    Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
    J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.